Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants

计划入组 12 人 · 首次发布于 2019 年 1 月 8 日

Effect of Genetic Variation in the Transporter OCT2, MATE1 and MATE2-K on the PKPD of Metformin

计划入组 41 人 · 首次发布于 2012 年 9 月 10 日

Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans

计划入组 33 人 · 首次发布于 2012 年 9 月 10 日

Mater Misericordiae Ltd.

Australia

Mater Misericordiae Hospital

United States

MATER RESEARCH LTD

Australia

Xeris Secures Additional Orange Book Patent Protection for Recorlev Through 2040

Mater Research Initiates Trial for Novavax's Combined COVID-19 and Flu Vaccine

Ireland's First Dedicated Phase 1 Oncology Unit Opens in Dublin